#Prevention

Experts offer advice about how to stop and restart PrEP in the era of social distancing.

Hint: Gilead Sciences donated the meds for Trump’s HIV prevention program, so that cost isn’t the issue.

Scripts and testing don’t require visits to the doc thanks to this partnership between Texas Health Action and the telemedicine portals.

A clinical trial compared injectable cabotegravir given every eight weeks versus daily Truvada for HIV prevention.

Gilead Sciences provides the funds through its TRANScend initiative; Destination Tomorrow in the Bronx distributes them.

Mathematical models show that HIV gains in sub-Saharan Africa could be lost, say UNAIDS and WHO.

The bilingual “How Low Can You Go?” campaign offers “life-changing news” for more than 6,400 residents.

Experts recommend that everyone should wear cloth face masks in public.

A survey of local health departments reveals concerning news—and a silver lining.

As a result, researchers in Spain are testing whether HIV med Truvada, often used as PrEP, can also prevent COVID-19.

“Brave spaces” are needed, says Lamar Brown-Noguera of AIDS Project Worcester. Here’s how the group is adjusting to the COVID-19 crisis.

Screening mammograms should be postponed until later this year—or longer, if the coronavirus crisis continues.

Without swift unprecedented action, more than 2 million Americans could die.

Many 5-star nursing homes have infection-control lapses.

More than 230,000 women and girls have been diagnosed with HIV in the United States; this year’s theme focuses on prevention.